154 related articles for article (PubMed ID: 16651863)
1. Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G.
Wootla B; Dasgupta S; Mallet V; Kazatchkine MD; Nagaraja V; Friboulet A; Kaveri SV; Lacroix-Desmazes S
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):229-34. PubMed ID: 16651863
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV
N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243
[TBL] [Abstract][Full Text] [Related]
4. Catalytic activity of antibodies against factor VIII in patients with hemophilia A.
Lacroix-Desmazes S; Moreau A; Sooryanarayana ; Bonnemain C; Stieltjes N; Pashov A; Sultan Y; Hoebeke J; Kazatchkine MD; Kaveri SV
Nat Med; 1999 Sep; 5(9):1044-7. PubMed ID: 10470082
[TBL] [Abstract][Full Text] [Related]
5. Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies.
Wootla B; Rao DN; Friboulet A; Uda T; Lacroix-Desmazes S; Kaveri SV
Clin Rev Allergy Immunol; 2009 Oct; 37(2):97-104. PubMed ID: 19160072
[TBL] [Abstract][Full Text] [Related]
6. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII inhibitor with catalytic activity towards factor VIII.
Lacroix-Desmazes S; Sooryanarayana ; Moreau A; Kazatchkine MD; Kaveri SV
Haematologica; 2000 Oct; 85(10 Suppl):89-92. PubMed ID: 11187883
[TBL] [Abstract][Full Text] [Related]
8. Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
Lacroix-Desmazes S; Wootla B; Dasgupta S; Delignat S; Bayry J; Reinbolt J; Hoebeke J; Saenko E; Kazatchkine MD; Friboulet A; Christophe O; Nagaraja V; Kaveri SV
J Immunol; 2006 Jul; 177(2):1355-63. PubMed ID: 16818797
[TBL] [Abstract][Full Text] [Related]
9. High levels of catalytic antibodies correlate with favorable outcome in sepsis.
Lacroix-Desmazes S; Bayry J; Kaveri SV; Hayon-Sonsino D; Thorenoor N; Charpentier J; Luyt CE; Mira JP; Nagaraja V; Kazatchkine MD; Dhainaut JF; Mallet VO
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4109-13. PubMed ID: 15743915
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to factor VIII with catalytic activity.
Bayry J; Lacroix-Desmazes S; Pashov A; Stahl D; Hoebeke J; Kazatchkine MD; Kaveri SV
Autoimmun Rev; 2003 Jan; 2(1):30-5. PubMed ID: 12848973
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical characterization of factor VIII inhibitors.
Hoyer LW; Gawryl MS; de la Fuente B
Prog Clin Biol Res; 1984; 150():73-85. PubMed ID: 6431443
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic antibodies against factor VIII in hemophilia A.
Stollar BD
N Engl J Med; 2002 Feb; 346(9):702-3. PubMed ID: 11870249
[No Abstract] [Full Text] [Related]
13. Catalytic antibodies to factor VIII in haemophilia A.
Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S31-4. PubMed ID: 14567533
[TBL] [Abstract][Full Text] [Related]
14. Human anti-mouse immunoglobulins in sera of patients treated chronically with monoclonal antibody-purified factor VIII.
Haimovich J; Davis HM; Schreiber AB
Semin Hematol; 1990 Apr; 27(2 Suppl 2):11-5. PubMed ID: 2128852
[TBL] [Abstract][Full Text] [Related]
15. The properties of immune complexes formed by human antibodies to factor VIII.
Lazarchick J; Hoyer LW
J Clin Invest; 1977 Nov; 60(5):1070-9. PubMed ID: 908750
[TBL] [Abstract][Full Text] [Related]
16. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy.
Moccia F; Tognoni E; Boccaccio P
Ann Ital Med Int; 2000; 15(2):172-6. PubMed ID: 10920509
[TBL] [Abstract][Full Text] [Related]
17. IgG subclass changes in response to replacement therapy with clotting factor VIII.
Shakib F
Monogr Allergy; 1986; 19():262-5. PubMed ID: 3093849
[No Abstract] [Full Text] [Related]
18. Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A.
Kazatchkine MD; Sultan Y; Burton-Kee EJ; Mowbray JF
Clin Exp Immunol; 1980 Feb; 39(2):315-20. PubMed ID: 6771074
[TBL] [Abstract][Full Text] [Related]
19. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis.
Kalaga R; Li L; O'Dell JR; Paul S
J Immunol; 1995 Sep; 155(5):2695-702. PubMed ID: 7650397
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S
Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
